HER2-Positive Gynecologic Cancers — Proceedings from a Session Held During the Society of Gynecologic Oncology 2026 Annual Meeting on Women's Cancer

Featuring perspectives from Dr Joyce F Liu, Dr David M O’Malley and Dr Brian M Slomovitz, moderated by Dr O’Malley, including the following topics:Introduction (0:00)Strategies to Identify Patients with HER2-Positive Gynecologic Cancers — Dr Liu (2:52)Available Data with and Practical Application of HER2-Targeted Therapy in Advanced Gynecologic Cancers — Dr Slomovitz (25:16)Identification and Management of Adverse Events with Trastuzumab Deruxtecan — Dr O’Malley (1:00:31)CME information and select publications